Demonstration of effectiveness and tolerability of terconazole 80-mg vaginal suppositories (3 days) versus terconazole 240-mg vaginal suppositories (1 day) versus clotrimazole 200-mg vaginal tablets (3 days) in non-pregnant women with vulvovaginal candidosis.
D000935:Antifungal Agents / Q000008:administration & dosage*; D002181:Candidiasis, Vulvovaginal / Q000188:drug therapy*; D003022:Clotrimazole / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage*; D013488:Suppositories; D013607:Tablets; D014230:Triazoles / Q000008:administration & dosage*; D014621:Vagina
D000935:Antifungal Agents; D007093:Imidazoles; D013488:Suppositories; D013607:Tablets; D014230:Triazoles; C037815:terconazole; D003022:Clotrimazole